Fig. 5.

Age-standardised mortality rate associated with and attributable to AMR in relation to the status of NAPs for the countries in the WHO Region of the Americas. Rates per 100,000 person-years are coloured according to two dimensions NAP status: the highest self-reported government engagement with the NAP between 2018 and 2021 and whether the NAP was published online as reported in surveys or the WHO NAP website. Grey error bars indicate 95% uncertainty intervals. NAP data was acquired from the Global Database for Tracking Antimicrobial Resistance Country Self-Assessment Survey (TrACSS) responses for the years 2018–2021¹⁹ and the WHO library of AMR NAPs.²⁰ Estimates were aggregated across drugs, accounting for the co-occurrence of resistance to multiple drugs. Antigua and Barbuda, Dominica, Grenada, Haiti, Saint Kitts and Nevis and Venezuela AMR NAP progress was last reported in the 2018–2019 survey responses. AMR = antimicrobial resistance; NAP = national AMR action plan.